A Scientific Research Program to evaluate the effects of SYMBICORT 320/9µg in the treatment of COPD in real life environment by General Practitioners.

Study identifier:SRP-RB-COPD/2005/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Scientific Research Program to evaluate the effects of SYMBICORT 320/9µg in the treatment of COPD in real life environment by General Practitioners.

Medical condition

asthma

Phase

N/A

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

-

Age

-

Date

Study Start Date: 01 Jan 1971
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Dec 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria